HARVARD MANAGEMENT CO INC Holdings

HARVARD MANAGEMENT CO INC is an investment fund managing more than 803.74M US dollars. The largest holdings include Alphabet, Meta Platforms and Light & Wonder. In Q2 2022 the fund bought assets of total value of 44.55M US dollars and sold assets of total value of 90.56M US dollars.

$803.74M

portfolio value

-86.50%

quarter

-383.10%

1 year

-575.37%

3 years

-768.58%

5 years

HARVARD MANAGEMENT CO INC portfolio changes

Portfolio changes (number of shares)
Period	Buy	Sel
Q1 2016	91133000	150896000
Q2 2016	136973000	271165000
Q3 2016	74627000	9179000
Q4 2016	111126000	54401000
Q1 2017	738108000	247637000
Q2 2017	16542000	137130000
Q3 2017	11816000	2098000
Q4 2017	177000	864105000
Q1 2018	589825000	3316000
Q2 2018	113403000	365450000
Q3 2018	78465000	107111000
Q4 2018	156493000	67945000
Q1 2019	24769000	106805000
Q2 2019	95472000	82000000
Q3 2019	765690000	93218000
Q4 2019	97487000	230635000
Q1 2020	36928000	338821000
Q2 2020	823625000	298413000
Q3 2020	750875000	6805000
Q4 2020	621585000	743323000
Q1 2021	560920000	583288000
Q2 2021	550580000	618723000
Q3 2021	361401000	315344000
Q4 2021	153339000	681467000
Q1 2022	226489000	145928000
Q2 2022	44554000	90563000

HARVARD MANAGEMENT CO INC 13F holdings

Stock	Position type	Portfolio share	Portfolio value	Avg. open price	Current price	P/L	Last change
Internet Content & Information Alphabet Inc. Portfolio share: 28.70% Portfolio value: 230.66M Avg. open price: $2,448.92 Current price: $99.48 P/L: -95.94% Bought +38.46% shares Q2 2022	share	28.70%	230.66M	$2,448.92	$99.48	-95.94%	Bought +38.46% shares Q2 2022
Internet Content & Information Meta Platforms, Inc. Portfolio share: 19.18% Portfolio value: 154.12M Avg. open price: N/A Current price: $122.43 P/L: N/A Sold -7.73% shares Q2 2022	share	19.18%	154.12M	N/A	$122.43	N/A	Sold -7.73% shares Q2 2022
Gambling Light & Wonder, Inc. Portfolio share: 14.29% Portfolio value: 114.85M Avg. open price: N/A Current price: $63.62 P/L: N/A N/A Q3 2020	share	14.29%	114.85M	N/A	$63.62	N/A	N/A Q3 2020
Biotechnology AbCellera Biologics Inc. Portfolio share: 5.05% Portfolio value: 40.59M Avg. open price: N/A Current price: $11.91 P/L: N/A N/A Q4 2020	share	5.05%	40.59M	N/A	$11.91	N/A	N/A Q4 2020
Biotechnology EQRx, Inc. Portfolio share: 3.24% Portfolio value: 26.04M Avg. open price: N/A Current price: $3.46 P/L: N/A N/A Q4 2021	share	3.24%	26.04M	N/A	$3.46	N/A	N/A Q4 2021
Software—Application Grab Holdings Limited Portfolio share: 3.04% Portfolio value: 24.46M Avg. open price: $3.82 Current price: $3.1 P/L: -18.85% Bought +73.21% shares Q3 2022	share	3.04%	24.46M	$3.82	$3.1	-18.85%	Bought +73.21% shares Q3 2022
Pollution & Treatment Controls PureCycle Technologies, Inc. Portfolio share: 2.51% Portfolio value: 20.16M Avg. open price: $9.65 Current price: $6.86 P/L: -28.91% Bought +133.56% shares Q1 2022	share	2.51%	20.16M	$9.65	$6.86	-28.91%	Bought +133.56% shares Q1 2022
Biotechnology Recursion Pharmaceuticals, Inc. Portfolio share: 2.00% Portfolio value: 16.05M Avg. open price: N/A Current price: $9.11 P/L: N/A N/A Q2 2021	share	2.00%	16.05M	N/A	$9.11	N/A	N/A Q2 2021
Biotechnology Revolution Medicines, Inc. Portfolio share: 1.64% Portfolio value: 13.22M Avg. open price: N/A Current price: $24.32 P/L: N/A N/A Q1 2020	share	1.64%	13.22M	N/A	$24.32	N/A	N/A Q1 2020
Biotechnology Relay Therapeutics, Inc. Portfolio share: 1.51% Portfolio value: 12.10M Avg. open price: N/A Current price: $18.36 P/L: N/A N/A Q3 2020	share	1.51%	12.10M	N/A	$18.36	N/A	N/A Q3 2020
Biotechnology Pliant Therapeutics, Inc. Portfolio share: 1.46% Portfolio value: 11.74M Avg. open price: N/A Current price: $17 P/L: N/A N/A Q2 2020	share	1.46%	11.74M	N/A	$17	N/A	N/A Q2 2020
Shell Companies MELI Kaszek Pioneer Corp Portfolio share: 1.23% Portfolio value: 9.87M Avg. open price: N/A Current price: $9.97 P/L: N/A N/A Q3 2021	share	1.23%	9.87M	N/A	$9.97	N/A	N/A Q3 2021
Semiconductor Equipment & Materials ASML Holding N.V. Portfolio share: 1.04% Portfolio value: 8.38M Avg. open price: N/A Current price: $601.13 P/L: N/A N/A Q2 2022	share	1.04%	8.38M	N/A	$601.13	N/A	N/A Q2 2022
Semiconductors Qorvo, Inc. Portfolio share: 1.03% Portfolio value: 8.31M Avg. open price: $124.1 Current price: $97.56 P/L: -21.39% Bought +122.88% shares Q2 2022	share	1.03%	8.31M	$124.1	$97.56	-21.39%	Bought +122.88% shares Q2 2022
Semiconductors NVIDIA Corporation Portfolio share: 1.00% Portfolio value: 8.05M Avg. open price: $272.86 Current price: $166.1 P/L: -39.13% Bought +152.21% shares Q2 2022	share	1.00%	8.05M	$272.86	$166.1	-39.13%	Bought +152.21% shares Q2 2022
Semiconductors Analog Devices, Inc. Portfolio share: 0.95% Portfolio value: 7.60M Avg. open price: $165.18 Current price: $167.9 P/L: +1.65% Bought +30.74% shares Q2 2022	share	0.95%	7.60M	$165.18	$167.9	+1.65%	Bought +30.74% shares Q2 2022
Semiconductors Taiwan Semiconductor Manufacturing Company Limited Portfolio share: 0.92% Portfolio value: 7.35M Avg. open price: $104.26 Current price: $81.62 P/L: -21.71% Bought +66.49% shares Q2 2022	share	0.92%	7.35M	$104.26	$81.62	-21.71%	Bought +66.49% shares Q2 2022
Semiconductor Equipment & Materials Applied Materials, Inc. Portfolio share: 0.90% Portfolio value: 7.24M Avg. open price: $131.8 Current price: $106.43 P/L: -19.25% Bought +74.95% shares Q2 2022	share	0.90%	7.24M	$131.8	$106.43	-19.25%	Bought +74.95% shares Q2 2022
Semiconductors Advanced Micro Devices, Inc. Portfolio share: 0.88% Portfolio value: 7.10M Avg. open price: $109.34 Current price: $73.62 P/L: -32.67% Bought +105.34% shares Q2 2022	share	0.88%	7.10M	$109.34	$73.62	-32.67%	Bought +105.34% shares Q2 2022
Semiconductor Equipment & Materials Lam Research Corporation Portfolio share: 0.87% Portfolio value: 7.00M Avg. open price: $537.61 Current price: $452.6 P/L: -15.81% Bought +52.79% shares Q2 2022	share	0.87%	7.00M	$537.61	$452.6	-15.81%	Bought +52.79% shares Q2 2022
Biotechnology Kinnate Biopharma Inc. Portfolio share: 0.74% Portfolio value: 5.95M Avg. open price: N/A Current price: $7.05 P/L: N/A N/A Q4 2020	share	0.74%	5.95M	N/A	$7.05	N/A	N/A Q4 2020
Semiconductors Micron Technology, Inc. Portfolio share: 0.67% Portfolio value: 5.38M Avg. open price: $77.89 Current price: $54.04 P/L: -30.62% Bought +4.71% shares Q2 2022	share	0.67%	5.38M	$77.89	$54.04	-30.62%	Bought +4.71% shares Q2 2022
Semiconductors Intel Corporation Portfolio share: 0.67% Portfolio value: 5.35M Avg. open price: $49.56 Current price: $29.17 P/L: -41.14% Bought +37.76% shares Q2 2022	share	0.67%	5.35M	$49.56	$29.17	-41.14%	Bought +37.76% shares Q2 2022
Health Information Services 10x Genomics, Inc. Portfolio share: 0.66% Portfolio value: 5.30M Avg. open price: $181 Current price: $36.57 P/L: -79.80% Bought +108.04% shares Q2 2021	share	0.66%	5.30M	$181	$36.57	-79.80%	Bought +108.04% shares Q2 2021
Biotechnology Nurix Therapeutics, Inc. Portfolio share: 0.51% Portfolio value: 4.10M Avg. open price: N/A Current price: $12.38 P/L: N/A N/A Q3 2020	share	0.51%	4.10M	N/A	$12.38	N/A	N/A Q3 2020
Aerospace & Defense Rocket Lab USA, Inc. Portfolio share: 0.51% Portfolio value: 4.07M Avg. open price: N/A Current price: $4.15 P/L: N/A N/A Q3 2021	share	0.51%	4.07M	N/A	$4.15	N/A	N/A Q3 2021
Biotechnology Fulcrum Therapeutics, Inc. Portfolio share: 0.41% Portfolio value: 3.32M Avg. open price: N/A Current price: $6.56 P/L: N/A N/A Q3 2019	share	0.41%	3.32M	N/A	$6.56	N/A	N/A Q3 2019
Software—Infrastructure Affirm Holdings, Inc. Portfolio share: 0.41% Portfolio value: 3.25M Avg. open price: $67.35 Current price: $12.99 P/L: -80.72% Sold -76.98% shares Q4 2021	share	0.41%	3.25M	$67.35	$12.99	-80.72%	Sold -76.98% shares Q4 2021
Software—Infrastructure Confluent, Inc. Portfolio share: 0.39% Portfolio value: 3.09M Avg. open price: N/A Current price: $20.38 P/L: N/A N/A Q4 2021	share	0.39%	3.09M	N/A	$20.38	N/A	N/A Q4 2021
Biotechnology Sana Biotechnology, Inc. Portfolio share: 0.35% Portfolio value: 2.81M Avg. open price: $19.66 Current price: $4.35 P/L: -77.87% Sold -59.72% shares Q4 2021	share	0.35%	2.81M	$19.66	$4.35	-77.87%	Sold -59.72% shares Q4 2021
Biotechnology Generation Bio Co. Portfolio share: 0.34% Portfolio value: 2.71M Avg. open price: $30.91 Current price: $5.22 P/L: -83.11% Sold -0.39% shares Q3 2021	share	0.34%	2.71M	$30.91	$5.22	-83.11%	Sold -0.39% shares Q3 2021
Biotechnology Vigil Neuroscience, Inc. Portfolio share: 0.33% Portfolio value: 2.63M Avg. open price: N/A Current price: $12 P/L: N/A N/A Q1 2022	share	0.33%	2.63M	N/A	$12	N/A	N/A Q1 2022
Biotechnology Tango Therapeutics, Inc. Portfolio share: 0.32% Portfolio value: 2.56M Avg. open price: N/A Current price: $7.69 P/L: N/A N/A Q3 2021	share	0.32%	2.56M	N/A	$7.69	N/A	N/A Q3 2021
PureCycle Technologies, Inc. Portfolio share: 0.30% Portfolio value: 2.42M Avg. open price: N/A Current price: $2.9 P/L: N/A N/A Q1 2022	share	0.30%	2.42M	N/A	$2.9	N/A	N/A Q1 2022
Biotechnology Tenaya Therapeutics, Inc. Portfolio share: 0.24% Portfolio value: 1.95M Avg. open price: N/A Current price: $2.42 P/L: N/A N/A Q3 2021	share	0.24%	1.95M	N/A	$2.42	N/A	N/A Q3 2021
Nauticus Robotics Inc. Portfolio share: 0.22% Portfolio value: 1.80M Avg. open price: N/A Current price: N/A P/L: N/A N/A Q3 2022	share	0.22%	1.80M	N/A	N/A	N/A	N/A Q3 2022
Biotechnology Praxis Precision Medicines, Inc. Portfolio share: 0.22% Portfolio value: 1.76M Avg. open price: N/A Current price: $2.14 P/L: N/A Sold -1.78% shares Q1 2021	share	0.22%	1.76M	N/A	$2.14	N/A	Sold -1.78% shares Q1 2021
Biotechnology Surrozen, Inc. Portfolio share: 0.21% Portfolio value: 1.67M Avg. open price: N/A Current price: $0.54 P/L: N/A N/A Q3 2021	share	0.21%	1.67M	N/A	$0.54	N/A	N/A Q3 2021
Biotechnology Dyne Therapeutics, Inc. Portfolio share: 0.17% Portfolio value: 1.36M Avg. open price: N/A Current price: $11.47 P/L: N/A N/A Q3 2020	share	0.17%	1.36M	N/A	$11.47	N/A	N/A Q3 2020
Medical Devices Pacific Biosciences of California, Inc. Portfolio share: 0.17% Portfolio value: 1.33M Avg. open price: N/A Current price: $10.03 P/L: N/A N/A Q3 2021	share	0.17%	1.33M	N/A	$10.03	N/A	N/A Q3 2021
Biotechnology Xilio Therapeutics, Inc. Portfolio share: 0.15% Portfolio value: 1.21M Avg. open price: N/A Current price: $2.43 P/L: N/A N/A Q4 2021	share	0.15%	1.21M	N/A	$2.43	N/A	N/A Q4 2021
Biotechnology Decibel Therapeutics, Inc. Portfolio share: 0.14% Portfolio value: 1.13M Avg. open price: N/A Current price: $3 P/L: N/A N/A Q1 2021	share	0.14%	1.13M	N/A	$3	N/A	N/A Q1 2021
Education & Training Services Laureate Education, Inc. Portfolio share: 0.13% Portfolio value: 1.07M Avg. open price: N/A Current price: $10.15 P/L: N/A N/A Q3 2022	share	0.13%	1.07M	N/A	$10.15	N/A	N/A Q3 2022
Biotechnology Seres Therapeutics, Inc. Portfolio share: 0.11% Portfolio value: 846K Avg. open price: N/A Current price: $6.53 P/L: N/A N/A Q4 2020	share	0.11%	846K	N/A	$6.53	N/A	N/A Q4 2020
Biotechnology Pardes Biosciences, Inc. Portfolio share: 0.09% Portfolio value: 740K Avg. open price: N/A Current price: $1.1 P/L: N/A N/A Q4 2021	share	0.09%	740K	N/A	$1.1	N/A	N/A Q4 2021
Biotechnology Magenta Therapeutics, Inc. Portfolio share: 0.06% Portfolio value: 469K Avg. open price: $12.01 Current price: $1.24 P/L: -89.68% Sold -19.15% shares Q1 2019	share	0.06%	469K	$12.01	$1.24	-89.68%	Sold -19.15% shares Q1 2019
Biotechnology Gemini Therapeutics, Inc. Portfolio share: 0.05% Portfolio value: 410K Avg. open price: N/A Current price: $1.7 P/L: N/A N/A Q1 2021	share	0.05%	410K	N/A	$1.7	N/A	N/A Q1 2021

Showing TOP 47 HARVARD MANAGEMENT CO's 13F holdings.

Frequently Asked Questions (FAQ)

What is the biggest position of HARVARD MANAGEMENT CO INC?

The biggest position of the HARVARD MANAGEMENT CO INC is Alphabet Inc. (GOOGL) with 28.7% portfolio share worth of 230.66M US dollars.

Top 5 HARVARD MANAGEMENT CO's holdings represent 70.46% of the portfolio:

Alphabet Inc. (GOOGL) – 28.7%
Meta Platforms, Inc. (META) – 19.18%
Light & Wonder, Inc. (LNW) – 14.29%
AbCellera Biologics Inc. (ABCL) – 5.05%
EQRx, Inc. (EQRX) – 3.24%

Who is the portfolio manager of HARVARD MANAGEMENT CO INC?

The portfolio manager of the HARVARD MANAGEMENT CO INC is .

What is the total asset value of the HARVARD MANAGEMENT CO INC portfolio?

HARVARD MANAGEMENT CO INC total asset value (portfolio value) is 803.74M US dollars.

Who is ?

is the portfolio manager of the HARVARD MANAGEMENT CO INC.

What is (HARVARD MANAGEMENT CO INC) fund performance?

HARVARD MANAGEMENT CO's quarterly performance is -86.50%, annualy -383.10%. In the past 3 years, the value of 's portfolio has decreased by -575%. In the past 5 years, the value of the portfolio has decreased by -769%.

What is the HARVARD MANAGEMENT CO INC CIK?

HARVARD MANAGEMENT CO's Central Index Key is 0001082621 .

HARVARD MANAGEMENT CO INC Holdings

HARVARD MANAGEMENT CO INC portfolio value:

HARVARD MANAGEMENT CO INC quarter portfolio value change:

HARVARD MANAGEMENT CO INC 1 year portfolio value change:

HARVARD MANAGEMENT CO INC 3 years portfolio value change:

HARVARD MANAGEMENT CO INC 5 years portfolio value change: